Regulations.gov document
Appendix D FDA Briefing Document NDA 206089 Testosterone Undecanoate (proposed trade name…
Supporting & Related Material · FDA-2019-P-4644 · posted Oct 9, 2019
Key facts
| Document ID | FDA-2019-P-4644-0007 |
|---|---|
| Title | Appendix D FDA Briefing Document NDA 206089 Testosterone Undecanoate (proposed trade name Jatenzo) re Citizen Petition from Clarus Therapeutics, Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2019-P-4644 |
| Posted | Oct 9, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: